Antisense epidermal growth factor receptor delivered by adenoviral vector blocks tumor growth in human gastric cancer (original) (raw)

Cancer Gene Therapy volume 6, pages 423–427 (1999)Cite this article

Abstract

Epidermal growth factor receptor (EGFR) protein overexpression is commonly found in human gastric cancer, and its gene amplification is known to correlate with poor prognosis in gastric cancer patients. With regard to therapy trials targeting EGFR, it has been reported that stable transfection of EGFR antisense or treatment with antibody against EGFR results in growth suppression of human cancer cells that express high levels of EGFR. We have designed an adenovirus-expressing antisense EGFR and have investigated its effect on the growth of gastric cancer in vitro and in vivo. Following infection with EGFR antisense RNA-expressing adenovirus (Ad-EAS), the cell surface EGFR protein levels of infected cancer cells were markedly reduced, and the in vitro growth of Ad-EAS-infected cells was significantly inhibited relative to control-infected cells in all three gastric cancer cell lines (AGS, KKLS, and MKN28) studied here (P < .0002). In a nude mouse subcutaneous tumor system, in vivo tumor growth of MKN28 was significantly inhibited after Ad-EAS treatment, and inhibition on day 48 was 93% by volume compared with that of untreated controls. These results suggest that an adenoviral vector system targeting the down-regulation of EGFR could be a good candidate for the therapy of gastric cancers that overexpress EGFR.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. First Department of Surgery, Nara Medical University, Nara, Japan
    Tomoko Hirao, Hidetomo Sawada, Fumikazu Koyama, Akihiko Watanabe, Yukishige Yamada, Teruyuki Sakaguchi, Mitsutoshi Tatsumi, Heisuke Fujimoto, Kouji Emoto, Michihiro Narikiyo & Hiroshige Nakano
  2. Department of Otolaryngology, Hokkaido University School of Medicine, Hokkaido, Japan
    Nobuhiko Oridate

Authors

  1. Tomoko Hirao
    You can also search for this author inPubMed Google Scholar
  2. Hidetomo Sawada
    You can also search for this author inPubMed Google Scholar
  3. Fumikazu Koyama
    You can also search for this author inPubMed Google Scholar
  4. Akihiko Watanabe
    You can also search for this author inPubMed Google Scholar
  5. Yukishige Yamada
    You can also search for this author inPubMed Google Scholar
  6. Teruyuki Sakaguchi
    You can also search for this author inPubMed Google Scholar
  7. Mitsutoshi Tatsumi
    You can also search for this author inPubMed Google Scholar
  8. Heisuke Fujimoto
    You can also search for this author inPubMed Google Scholar
  9. Kouji Emoto
    You can also search for this author inPubMed Google Scholar
  10. Michihiro Narikiyo
    You can also search for this author inPubMed Google Scholar
  11. Nobuhiko Oridate
    You can also search for this author inPubMed Google Scholar
  12. Hiroshige Nakano
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Hirao, T., Sawada, H., Koyama, F. et al. Antisense epidermal growth factor receptor delivered by adenoviral vector blocks tumor growth in human gastric cancer.Cancer Gene Ther 6, 423–427 (1999). https://doi.org/10.1038/sj.cgt.7700058

Download citation

Keywords